Reform has unleashed Chinese drugs innovation boom, though some pharma firms may not survive under intense price pressure, industry leaders say

Reform has unleashed Chinese drugs innovation boom, though some pharma firms may not survive under intense price pressure, industry leaders say

Reform has unleashed Chinese drugs innovation boom, though some pharma firms may not survive under intense price pressure, industry leaders say


China’s drug developers are expected to ride on a surge in the size of the domestic market driven by policy reform, though intense price pressure will see off contenders failing to innovate, according to speakers at an industry conference.The contribution of newly developed medicines – often referred to in the industry as novel or innovative drugs – to total sales in China’s pharmaceutical industry may rise to 36 per cent by 2025 from 22 per cent in 2017, said Song Ruilin, executive president…

Source link